Les infos clés
En résumé
Welcome to Understanding Prostate Cancer. My name is Ken Pienta, Professor of Urology and Oncology at the Johns Hopkins School of Medicine. I have been studying prostate cancer and treating patients with prostate cancer for over 25 years. Over 1,000,000 men worldwide and 230,000 men in the United States are diagnosed with prostate cancer every year. Three hundred thousand men worldwide and 30,000 men in the US are dying from prostate cancer every year. As people live longer, the incidence of prostate cancer is rising worldwide and prostate cancer continues to be a major health problem. Thanks to years of dedication and commitment to research we’ve made enormous advances in the treatment of prostate cancer, But there is still a lot of work to be done. In this Understanding Prostate Cancer course, I will provide an introduction to the biology of prostate cancer as well as how it is identified and treated at various stages of the disease. I've put together this course in order to introduce you to the essentials of prostate cancer. By the time you finish this course you'll be able to Define risk factors for prostate cancer Understand current prostate cancer screening guidelines Understand prostate cancer staging Understand treatments for localized prostate cancer Understand treatments for advanced prostate cancer Understand treatments to alleviate the symptoms caused by prostate cancer This Understanding Prostate Cancer Course should be helpful to anyone who wants to develop a deeper understanding of prostate cancer biology and treatment. It should be useful to students who are interested in a deeper understanding of the science of cancer. It should also be helpful to health care providers, data managers, and educators who wish to develop a better understanding of prostate cancer and how it affects individuals. The course is not designed for patients seeking treatment guidance. For those of you who might be thinking about a career in cancer research or patient care, I hope this course will inspire you to pursue that path! The course is divided into five modules organized to facilitate learning. I'm glad that you decided to join this course. I hope that you will develop a basic understanding of prostate cancer. I hope that it will help you in whatever field you work. If you are a student, I hope that what you learn here will help you begin a career in cancer biology research and contribute to the worldwide effort to save lives.
Le programme
- Week 1 - Welcome to Understanding Prostate Cancer
Welcome to Understanding Prostate Cancer - Week 1 - Biology, Incidence, and Risk Factors for Prostate Cancer
in this module you will be able to learn about the biology, incidents, and risk factors of prostate cancer, as well as prostate cancer screening. - Week 2 - How Prostate Cancer is Found, Diagnosed, and Staged
In this module you will be able to examine how prostate cancer is found, diagnosed, and staged. - Week 2 - How Localized Prostate Cancer is Treated
In this module you will be able to learn how localized prostate cancer is treated and the side effects of treatment. - Week 3 - Treatment of Metastatic Prostate Cancer
In this module, you will be able to learn how advanced prostate cancer is treated. This includes chemotherapy, immunotherapy, and hormone therapy. - Week 3 - Other Treatments to Support the Health of Prostate Cancer Patients
In this module, you will learn supportive treatments for patients of prostate cancer.
Les intervenants
Kenneth J. Pienta, M.D.
The Donald S. Coffey Professor of Urology
The James Buchanan Brady Urological Institute
Le concepteur
L’université Johns-Hopkins (Johns Hopkins University, ou JHU) est une université privée américaine, située à Baltimore dans le Maryland. Elle possède également des campus à Washington, à Bologne en Italie, à Singapour et à Nankin en Chine. Elle doit son nom à Johns Hopkins, un entrepreneur fortuné qui a légué à sa mort 7 millions de dollars à l'université.
Comptant parmi les universités les plus prestigieuses des États-Unis (surtout pour ses facultés de médecine et de santé publique, ainsi que pour son école d'affaires internationales), l'institution se définit comme la première « université de recherche » du pays. Au début de son histoire, elle s'est principalement inspirée de l'université de Heidelberg et du modèle d'instruction allemand de Wilhelm von Humboldt. En 2019, 39 lauréats du prix Nobel ont leur nom associé à l'université.
La plateforme
Coursera est une entreprise numérique proposant des formations en ligne ouverte à tous fondée par les professeurs d'informatique Andrew Ng et Daphne Koller de l'université Stanford, située à Mountain View, Californie.
Ce qui la différencie le plus des autres plateformes MOOC, c'est qu'elle travaille qu'avec les meilleures universités et organisations mondiales et diffuse leurs contenus sur le web.
Based solely on the Week 3 content (treatment of metastatic prostate cancer), I highly recommend this course. After viewing many other videos on cancer generally and prostate cancer specifically, it was great to find a source that, in about 45 minutes, tells what treatments are appropriate and when, gives information on how long each option buys the patient, clearly and frankly describes side effects, and describes which side effects can be treated and how. All of the information was presented exactly on the level I was looking for. I am not a medical professional, just someone who has completed freshman biology (MIT 7.00x). I especially enjoyed the part about mutations in the tumor guiding treatment ("precision medicine"), and wish there had been more on that subject.
Based solely on the Week 3 content (treatment of metastatic prostate cancer), I highly recommend this course. After viewing many other videos on cancer generally and prostate cancer specifically, it was great to find a source that, in about 45 minutes, tells what treatments are appropriate and when, gives information on how long each option buys the patient, clearly and frankly describes side effects, and describes which side effects can be treated and how. All of the information was presented exactly on the level I was looking for. I am not a medical professional, just someone who has completed freshman biology (MIT 7.00x). I especially enjoyed the part about mutations in the tumor guiding treatment ("precision medicine"), and wish there had been more on that subject.